Adjunctive Nebulised N‐Acetylcysteine for Laryngopharyngeal Symptoms Persisting Despite Proton‐Pump‐Inhibitor Therapy: A Prospective Single‐Arm Interventional Study
Clinical Otolaryngology · 13.11.2026
DOI: 10.1111/coa.70195 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Otolaryngology, online erschienen am 13.11.2026. Verfasst von Sang Heun Kim und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chungnam National University, Daejeon, Republic of Korea. Die Arbeit nennt 24 Literaturangaben. Gefördert von: Chungnam National University.
Abstract (Originalsprache)
Objectives
To quantify within‐subject change in symptom, laryngoscopic and quality‐of‐life measures after 8 weeks of adjunctive nebulised N‐acetylcysteine ( NAC ) in adults with laryngopharyngeal symptoms ( LPS ) persisting despite proton‐pump‐inhibitor ( PPI ) therapy, and to explore baseline predictors of response.
Design
Prospective, single‐arm, pre–post interventional study.
Setting
Tertiary otolaryngology practice.
Participants
Seventy‐five adults with LPS persisting after ≥ 12 weeks of PPI therapy (baseline Reflux Symptom Index [ RSI ] ≥ 13 and Reflux Finding Score [ RFS ] ≥ 7); ambulatory reflux monitoring was not performed. Main Outcome Measures Change in RSI (primary). Secondary: RFS, the 12‐item Reflux Symptom Score (RSS‐12) and the laryngopharyngeal reflux health‐related quality‐of‐life instrument (LPR‐HRQoL). Treatment response (≥ 50% RSI reduction or end‐of‐treatment RSI < 13) was modelled by logistic regression.
Results
All outcomes improved at Week 8: RSI −10.2 points (95% CI −11.2 to −9.2; Cohen's d_z = −2.33), RFS −6.1 (d_z = −1.88), RSS ‐12 − 33.9 (d_z = −1.30) and LPR ‐ HRQoL +20.0 (d_z = +2.17) (all p < 0.001). Thirty‐nine of 75 (52.0%) were responders. A twice‐daily PPI regimen was independently associated with response (adjusted odds ratio [ OR ] 4.96, 95% CI 1.41–17.43; p = 0.012) and higher baseline RSI with non‐response (adjusted OR 0.70 per point, 95% CI 0.56–0.87; p = 0.002).
Conclusions
Nebulised NAC with saline was associated with large improvements across symptom, laryngoscopic and quality‐of‐life domains in adults with LPS persisting despite PPI therapy and was well tolerated. As the study was uncontrolled and the saline vehicle may itself relieve symptoms, efficacy requires confirmation in a randomised trial against nebulised saline.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
- Convergence Medical Institute, College of Medicine, Chungnam National University, Daejeon, Republic of Korea.
ORCID-Profile: Sumin Yi, Han Wool John Sung, Bon Seok Koo, Jae Won Chang
Förderung
- Chungnam National University
Zitieren
APA
Kim, S. H., Yi, S., Sung, H. W. J., Son, H. O., Koo, B. S., & Chang, J. W. (2026). Adjunctive Nebulised N‐Acetylcysteine for Laryngopharyngeal Symptoms Persisting Despite Proton‐Pump‐Inhibitor Therapy: A Prospective Single‐Arm Interventional Study. Clinical Otolaryngology. https://doi.org/10.1111/coa.70195
Vancouver
Kim SH, Yi S, Sung HWJ, Son HO, Koo BS, Chang JW. Adjunctive Nebulised N‐Acetylcysteine for Laryngopharyngeal Symptoms Persisting Despite Proton‐Pump‐Inhibitor Therapy: A Prospective Single‐Arm Interventional Study. Clinical Otolaryngology. 2026. doi:10.1111/coa.70195
BibTeX
@article{Kim2026,
author = {Kim, Sang Heun and Yi, Sumin and Sung, Han Wool John and Son, Hyo One and Koo, Bon Seok and Chang, Jae Won},
title = {Adjunctive Nebulised N‐Acetylcysteine for Laryngopharyngeal Symptoms Persisting Despite Proton‐Pump‐Inhibitor Therapy: A Prospective Single‐Arm Interventional Study},
journal = {Clinical Otolaryngology},
year = {2026},
doi = {10.1111/coa.70195}
}
EUVIMED